Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7533
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)
Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)
This is a comparative analysis between a Placebo and Atorvastatin in terms of Cumulative Hazard (%) over a period of four years. The Hazard Ratio (HR) for Atorvastatin is 0.63 with a 95% confidence interval of 0.48-0.83, indicating a significant difference between the two groups. The p-value is 0.001, suggesting that the difference is statistically significant. The graph or table shows the Time to First Primary Endpoint across the four-year follow-up period.*
Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)
This text provides data on the percentage of subjects experiencing an event for two different doses of Atorvastatin (10 mg and 80 mg). It also includes hazard ratio (HR) with confidence intervals and p-value for the comparison of the two doses in relation to time to first major cardiovascular endpoint over several years.*
Label Image (Lbl500907533)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.